Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

FDA Panel: BioMarin Muscular Dystrophy Drug Trials Didn’t Prove Effectiveness

November 25, 2015 | by Thomas M. Burton, The Wall Street Journal | News | Comments

A Food and Drug Administration advisory panel concluded that a new drug from BioMarin Pharmaceutical Inc. hasn’t been proven to effectively treat the fatal disease called Duchenne muscular dystrophy, saying studies simply didn’t prove the medicine worked in most patients. Read more...

View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Researchers Urge Caution in Prescribing Commonly Used Drug to Treat ADHD

November 25, 2015 11:29 am | News | Comments

Authors of new Cochrane Review remain uncertain about effect of widely used medicine on ADHD symptoms, despite large amount of research. Some evidence of increased sleeplessness and loss of appetite leads researchers to encourage more caution in use of methylphenidate. Read more...


Research Team Finds That Protein Motions Regulate HIV Infectivity

November 25, 2015 11:20 am | by University of Delaware | News | Comments

Nearly 37 million people worldwide are living with HIV. When the virus destroys so many immune cells that the body can't fight off infection, AIDS will develop. The disease took the lives of more than a million people last year. Read more...


Drug Discovery Spotlight: Pfizer-Allergan Merger; FDA Approvals; and More

November 25, 2015 11:11 am | by Stephanie Guzowski, Editor | News | Comments

Welcome to Drug Discovery Spotlight, where we’ve rounded up this week’s trending headlines. Read more..


Drug Combination for Advanced Prostate Cancer

November 25, 2015 11:10 am | by University of Montreal Hospital Research Centre (CRCHUM) | News | Comments

A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide. Read more...


Researchers Study Alzheimer’s Disease in People with Down Syndrome

November 25, 2015 11:02 am | by Columbia University | News | Comments

The risk of Alzheimer’s disease—the most common cause of dementia—increases as a person ages. But the risk of Alzheimer’s is increased dramatically for adults with Down syndrome. Read more...


Human Cell Cloning Method Dramatically Improved, says Study

November 25, 2015 10:55 am | by Cynthia Fox, Science Editor | Articles | Comments

Upping the stakes in the enduring competition between pluripotent/embryonic stem cells made via the iPSC method, and via cloning, a Harvard University group has reported dramatically improving the efficiency of cloning. Read more...


Immune-disorder Treatment in Mice Holds Potential for Multiple Sclerosis Patients

November 25, 2015 9:27 am | by University of Florida | News | Comments

A University of Florida Health researcher has found a simple, rapid way to treat an immune-related disorder in mice, an approach that could eventually help multiple sclerosis patients after further research. Read more...


Scientists Reveal Potential Treatment for Life-Threatening Viral Infections

November 25, 2015 9:24 am | by The Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown for the first time how a previously unknown process works to promote infection in a number of dangerous viruses, including dengue, West Nile and Ebola. Read more...


Non-Disease Proteins Kill Brain Cells

November 25, 2015 8:17 am | by Trinity College Dublin | News | Comments

They made their comparisons in cells and animal models, and via experiments that studied electrical ‘brainwave’ responses in these cells. Read more...


Mylan Launches Generic FazaClo Orally Disintegrating Tablets

November 25, 2015 8:16 am | News | Comments

This drug is used for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. Read more...


FDA Approves Lilly's Portazza for Specific Type of Lung Cancer

November 25, 2015 7:45 am | News | Comments

Portrazza has been granted Orphan Drug Designation by the FDA. Read more...


"Good" Mozzie Virus Might Hold Key to Fighting Human Disease

November 25, 2015 7:30 am | by University of Queensland | News | Comments

Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes. Read more...

Global Gaucher Disease Treatment Market Value Will Reach $1.16B by 2024

November 25, 2015 7:15 am | by Edit Kovalcsik, Ph.D., Analyst, Cardiovascular and Metabolic Disorders | News | Comments

This increase can be attributed to continued efforts by Genzyme and Shire to raise awareness of such a rare condition as Gaucher disease. Read more...


Why Poo Transplants are Nothing to Be Sniffed At

November 25, 2015 7:00 am | by The Conversation, Tim Spector of King's College London | News | Comments

Five years in the future we could be popping capsules to cure us and reboot our healthy gut community made up of our frozen poo we stored when we were healthy. Read more...


Experts Foresee Big Premium Increases for Medicare Drug Plan

November 24, 2015 12:21 pm | by Ricardo Alonso-Zaldivar, Associated Press | News | Comments

With time running out on open enrollment season, many seniors are facing sharply higher premiums for Medicare's popular prescription drug program. The reason: rising drug costs have overtaken a long stretch of stable premiums. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.